Focus Stocks
Resistance Above for Merck?
Published on Tuesday, 07 September 2010 06:16 Written by Christopher Lynn
New York, September 7th (TradersHuddle.com) - Shares of Merck & Co. Inc. (NYSE:MRK) closed the trading session at $35.59 near its 50 day and 200 day moving averages currently set at $35.24 and $36.11 respectively. Merck's price action is above the 50 day moving average but below its 200 day moving average, which provide a nice trading setup, with clear reference points.
Merck & Co., Inc. (NYSE:MRK), the global pharmaceutical company that develops, manufactures, and markets a broad range of human and animal health products. Merck's products include Zocor for treatment of elevated cholesterol, Propecia for treatment for male pattern hair loss, Fosamax for preventive treatment of osteoporosis, and Singulair for treatment of asthma. Merck was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Merck price action seems to be setting up for a tight range between the 50 day moving average as support and the 200 day moving average serving as resistance.
A tiered approach to enter the stock, appears to be the best way to maximize possible movements from the stock, as traders could enter Merck with a small position and wait for the stock to break out above the 200 day moving average at $36.11, where traders could add to their position as momentum builds with the breakout. The flip side will be if support being referenced at the 50 day moving average set at $35.24 breaks it could mean further downside in the horizon for Merck.
Related Articles
- Merck Provides Update on Development Program for Suvorexant, an Investigational Orexin Receptor Antagonist for the Treatment of Insomnia
- Approaching Resistance - Merck
- Bank of America - Top Performing Dow Component
- Research Analyst's Up/Downgrades ( APKT, BRCD, CVC, KMX, HVB, LINTA, AGP, MRK, IP )
- Bears Appeared - Merck
- FDA Approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for Type 2 Diabetes, Offering the Powerful Efficacy of JANUMET® (sitagliptin/metformin HCl) Now Available with Once-Daily Convenience
- Dow's Top Performers :AA, BAC, AXP
- Stocks Tread Water on Mixed Earnings and Bernanke Testimony
- Stock Futures Flat amid Earnings. Stocks to Watch: AAPL, BAC, COST, GMCR, LVS, MRK, QCOM, WYNN
- Merck Announces Full-Year and Fourth-Quarter 2011 Financial Results
Related Partner Headlines
- Merck Confirms Plans to File NDA for Suvorexant in 2012 - Benzinga
- FDA Approves JANUMET XR for Type 2 Diabetes - Benzinga
- Dow Today: Merck (MRK) Lower - TheStreet.com
- Merck, Pfizer: Dow Midday Movers - TheStreet.com
- UPDATE: Merck Swings To Q4 Profit - Benzinga
- Merck's Earnings Are Up, But a Huge Drop may be Coming - Benzinga
- Merck Beats, Expects Flat 2012 Adjusted EPS - TheStreet.com
- Dow Today: Merck (MRK) Leads The Day Higher, Travelers Companies (TRV) Lags - TheStreet.com
- Merck Stock Hits New 52-Week High (MRK) - TheStreet.com
- Dow Today: Merck (MRK) Higher - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Some Thoughts at the End of the 2011-2012 Football Season - Benzinga -
Benzinga's Microcap Movers for Monday February 6, 2012 - Benzinga -
ETFs to Watch February 7, 2012 - Benzinga -
Market Preview: Coke Lacks Fizz - TheStreet.com -
'Fast Money' Recap: Headwinds for Netflix? - TheStreet.com -
Benzinga's M&A Chatter for Monday February 6, 2012 - Benzinga -
Benzinga's M&A Chatter for Monday February, 2012 - Benzinga -
'Mad Money Lightning Round': Go With General Mills - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,845.13 Trade time:4:06PM EST Value change:▼17.10 (-0.13%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,344.33 Trade time:4:32PM EST Value change:▼0.57 (-0.04%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,901.99 Trade time:5:16PM EST Value change:▼3.67 (-0.13%)In The Wires
-
Fleishman-Hillard Takes Majority Interest in Leading Moscow Consultancy; Fleishman-Hillard Vanguard to Serve as Hub in CIS Countries -
Advanced Semiconductor Engineering, Inc. Announces Monthly Net Revenues -
QLogic Gains Fibre Channel Adapter Share in Calendar Year 2011, Marking Eighth Consecutive Year of Market Leadership -
ArcelorMittal Reports Fourth Quarter 2011 and Full Year 2011 Results -
Omega Announces Fourth Quarter 2011 Financial Results; Adjusted FFO of $0.50 Per Share for the Fourth Quarter; and $334 Million of New Investments -
Walmart Unveils “Great For You” Icon -
Nebraska Liquor Licenses Can Now be Renewed Online -
Analog Devices’ Webcast Addresses The Fundamentals Of Laying Out PC Boards










